We have to undo problems that they have from medicines that they got in random ways. Its unlikely the drugs will stay on the FDAs shortage list forever
Lilly's Oral GLP-1, Orforglipron, Demonstrated Meaningful Weight Loss and Cardiometabolic Improvements in Complete ATTAIN-1 Results Published in The New England Journal of Medicine
Many of the neuroprotective, neurodegenerative, psychiatric, and addiction-related applications discussed remain investigational, and no GLP-1 receptor agonist is currently approved by regulatory authorities for the treatment or prevention of Alzheimers disease, Parkinsons disease, depression, substance use disorders, or other neurological indications unless specifically stated otherwise
Lancet 384 , 607617 (2014)
Yes, many compounding pharmacies provide these peptides pre-mixed in the same vial